Analyst consensus rating
Cytosorbents Analyst Rating: Hold
CTSO is rated Hold by 2 analysts with a $2.38 target. As of 2026-08-24.
Direct answer
Cytosorbents's consensus rating is Hold.
2 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $2.38.
Forecast evidence checked August 24, 2026.
Get free Cytosorbents email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $0.37
- Average price target
- $2.38
- High price target
- $4.00
- Low price target
- $0.75
- Low target gap
- +102.7%
- Target upside
- +541.9%
- High target gap
- +981.1%
- Target range width
- 878.4%
- Consensus rating
- Hold
- Analysts
- 2
- Evidence date
- August 24, 2026
- Valid through
- August 31, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Cytosorbents?
Cytosorbents has a verified Hold consensus. The same dataset has an average price target of $2.38.
How far are Cytosorbents's low and high targets from the recorded price?
The low target implies +102.7%, while the high target implies +981.1%.
How many analysts are included in Cytosorbents's consensus?
The verified consensus includes 2 analysts.
How is Cytosorbents's target upside or downside calculated?
The average target of $2.38 is divided by the recorded price of $0.37, then one is subtracted to produce +541.9%. This does not guarantee a future return.
When was Cytosorbents's analyst forecast verified?
The data was verified on 2026-08-24. The dataset is valid through 2026-08-31.